InvestorPlace Research Staff

Recent Articles

Investors Can Still Stay Patient with Hyliion Stock

This might not be the right market for HYLN stock, for a number of reasons. But the long-term case remains sound, and a rally should arrive at some point.

Why I’m Excited About One of the Craziest Market Days I’ve Ever Seen

As action in GME and AMC proved today, speculative trading is real. Here's what you need to focus on when the market gets topsy-turvy.

Avoid Nikola Stock Even As EV Holdings Remain Hot

Nikola never deserved to sport a $28 billion market cap and one could argue that NKLA stock doesn't deserve its current valuation of $8 billion either.

There’s No Need to Chase CIIG Merger Now

EV plays like CIIC stock went nuts near the end of 2020. Even with a pullback so far in 2021, investors can and should stay patient.

MoneyLine Podcast: The Healthcare Tech Stocks You Need to Know About

In this week's MoneyLine episode, Matt talks about a group of stocks that have been quietly growing since before the pandemic.